Prosper Junior Bakiny
TMFPBakiny
Prosper Junior Bakiny is a contributing Motley Fool healthcare analyst covering biotechnology, pharmaceuticals, and healthcare stocks. Before The Motley Fool, Prosper wrote about investing topics ranging from stock market news to private equity for various companies. He holds a master’s degree in corporate finance from the University of Maryland Global Campus.
Recent Articles by Prosper Junior Bakiny

Mar 2, 2025
by Prosper Junior Bakiny
Where Will Eli Lilly Be in 5 Years?

Feb 28, 2025
by Prosper Junior Bakiny
1 Biotech Stock to Buy in 2025, and 1 to Avoid

Feb 25, 2025
by Prosper Junior Bakiny
Post-Earnings Dip: 2 Stocks to Buy Right Now

Feb 24, 2025
by Prosper Junior Bakiny
2 Stocks Down 59% and 34% to Buy and Hold

Feb 16, 2025
by Prosper Junior Bakiny
2 Beaten-Down Stocks to Avoid

Feb 15, 2025
by Prosper Junior Bakiny
Is Teladoc Stock a Buy?

Feb 10, 2025
by Prosper Junior Bakiny
2 Stocks to Buy With Less Than $40
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.